Herb company research funding.

[Guest guest]

All,

 

> I agree with you. Follow the money. The herb companies will

> immeasurably and directly benefit financially from this type of

> research. They should LEAD this initiative; it is part of their cost of

> doing business.

 

Well, not that they shouldn't but the odds might not good. Several of the

producers that I have interviewed, mostly in Japan, have decided that

funding research will cost them sales. Since in East Asia these products are

now legal in their makers markets, they have nothing to gain and everything

to lose. I have not followed this closely but I believe that the largest of the

Japanese pharmaceutical concerns, Tsumra, which has a large kampo

product line that is sold over the counter, has funded only one kampo RCT.

 

Bob

 

bob Paradigm Publications

www.paradigm-pubs.com 44 Linden Street

Robert L. Felt Brookline MA 02445

617-738-4664

 

 

---

[This E-mail scanned for viruses by Declude Virus]